Biocept Inc. (BIOC) stock surged during current market trading. Why is it so?
Biocept Inc. (NASDAQ: BIOC) stock gained by 3.13% in the current market trading. Biocept creates and sells molecular diagnostic tests that offer doctors with clinically useful information for treating and monitoring patients with a range of malignancies. What is happening? Quest Diagnostics has partnered with BIOC to layout laboratory testing facilities for their Target Selector […]
Currently, What Is Driving Biocept (BIOC) Stock Higher?
Shares of a leading provider of molecular diagnostic assays, products, and services Biocept Inc. (NASDAQ: BIOC) were rising 3.83% to trade at $5.15 in premarket trading at the time of the last check. In Tuesday’s session, Biocept stock closed at $4.96, down -2.17%. In contrast to the 0.48 million shares of average daily volume, BIOC […]
